Medical Developments International (MVP) has a market capitalization of approximately A$42M, trading at A$0.38 on the ASX. Market cap moves with the live share price.
Medical Developments International's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.8x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
Medical Developments International runs a net profit margin of -1.1%, a gross margin of 52.7%, and an operating margin of 0.8%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
Medical Developments International reported revenue of A
Medical Developments International does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Medical Developments International carries a debt-to-equity ratio of 0.06x and a current ratio of 6.07x, with a market beta of 1.39. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Medical Developments International (MVP) the key facts are: market cap A$42M, revenue A
Get Medical Developments International's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.